Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer

The aim of this study was to determine the role of antithyroglobulin antibody (ATA) serum as a marker of successful I-131 ablation therapy in differentiated thyroid cancer (DTC) patients with low serum thyroglobulin (Tg). A retrospective study was conducted on 60 patients (10 males and 50 females)....

Descripción completa

Detalles Bibliográficos
Autores principales: Dewi, Ayu Rosemeilia, Darmawan, Budi, Kartamihadja, Achmad Hussein Sundawa, Hidayat, Basuki, Masjhur, Johan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314657/
https://www.ncbi.nlm.nih.gov/pubmed/28217014
http://dx.doi.org/10.4103/1450-1147.174714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314657/
https://www.ncbi.nlm.nih.gov/pubmed/28217014
http://dx.doi.org/10.4103/1450-1147.174714

Ejemplares similares